logo

Health News

Share
Whether you are a young couple building a nest or seasoned parents looking for a change of scenery, there are number of places around the country that should be avoided, according to personal finance website WalletHub. They looked at mainly five categories for more practical considerations across...
Read More
CVS-Vending-Machines-091217.jpg CVS Pharmacy will be launching health and wellness vending machines across the country to offer healthy snacks, personal care items as well as over-the-counter products to the customers on the go. The automated machines will be placed in airports, hotels, transportation hubs etc. and can be accessed using credit and debit cards. Aug2017-072717.jpg We are well into the second half of 2017. Now, let's take a look at the biotech stocks awaiting word from the FDA in August. untreatable-gonorrhea-071017.jpg There is a growing concern among the medical experts on the spread of antibiotic resistant and untreatable gonorrhea. Read More
Acupuncture-Breastcancer-012218.jpg One of the major drawback of aromatase inhibitors, a class of drugs, commonly used in the management of estrogen receptor-positive (ER+) breast cancer is the debilitating joint pain. A large clinical trial, which involved a total of 226 patients from 11 cancer centers, has found that acupuncture can significantly reduce the troublesome joint pain caused by the aromatase inhibitors. Scientists-Discussion-010318.jpg Hysterectomy, which refers to the surgical removal of a woman's uterus, is the second most common gynecologic surgery performed in the United States, next only to Caesarean Sections. Pharma-122617.jpg A new study conducted by Johns Hopkins researchers suggests that there is an increased risk of uterine fibroids in African-American women with central centrifugal cicatricial alopecia. Read More

Bristol-Myers Says FDA Expands Approval Of Sprycel



Bristol-Myers Squibb Co. (BMY) announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel or dasatinib tablets to include the treatment of children with Philadelphia chromosome-positive or Ph+ chronic myeloid leukemia or CML in chronic phase or CP. The approval for...
Read More
BillGates-CuringAlzheimers-111317.jpg

Bill Gates Gives Big Donation To Fight Alzheimer's



Billionaire and Microsoft co-founder Bill Gates is making a personal investment of $50 million into the Dementia Discovery Fund, a venture capital fund that invests in projects and companies to develop treatments for the brain-wasting disease. The investment is not part of Gates' philanthropic Bill & Melinda Gates Foundation, which has focused primarily on infectious diseases.
Read More
Slide0-Alzheimers-081717.jpg

Race For A New Alzheimer's Drug



The development of Alzheimer's drugs has been marred by a high failure rate. A U.S. study, which analyzed how the Alzheimer's clinical trials fared during the period of 2002 to 2012, revealed a failure rate of 99.6% compared to a failure rate of 81% for cancer drugs.
Read More




Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
03/02/18OTICOTIPRIO(sNDA)FDA decision on OTIPRIO for acute otitis externa
02/28/18AERIRhopressa (NDA)FDA decision on Rhopressa for the treatment of patients with open-angle glaucoma or ocular hypertension
02/28/18LJPCLJPC-501 (angiotensin II) (NDA)FDA decion on LJPC-501 or the treatment of hypotension in adults with distributive or vasodilatory shock
02/23/18RHHBYEmicizumab (BLA)FDA decision on Emicizumab for haemophilia A with inhibitors
02/15/18EXELCABOMETYX (sNDA)FDA decision on CABOMETYX as first-line monotherapy for advanced renal cell carcinoma
02/14/18AMAG, AMAGMakena subcutaneous auto-injector (sNDA)FDA decision on subcutaneous version of Makena to reduce the risk of preterm birth
View All

FDA Device Approval
No Records Found
View All